Drug Trial Radar · NCT03523962
Pre-operative Alcohol Skin Solutions in Fractured Extremities
Last checked: Nov 19, 2026Latest source record: Oct 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8,485
Actual
Start
Aug 21, 2018
Primary completion
Mar 15, 2023
Study completion Feb 2, 2024
Sponsor
- Lead sponsor
- University of Maryland, BaltimoreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- McMaster University; Patient-Centered Outcomes Research Institute
- First posted
- May 14, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The prevention of infection is an important goal influencing peri-operative care of extremity fracture patients. Standard practice in the operative management of extremity fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for extremity fracture surgery.
Conditions
- Surgical Site Infection
- Unplanned Fracture-Related Reoperation
- Open Appendicular Fracture
- Closed Lower Extremity Fracture
- Pelvic Fracture
Interventions
DuraPrepDrug
The iodine-based treatment intervention is an antiseptic solution comprised of iodine povacrylex (0.7% free iodine) in 74% isopropyl alcohol. 3M™ DuraPrep™ \[3M Health Care, St Paul, MN\], will be the commercial product used.
ChloraPrepDrug
The CHG intervention is an antiseptic solution comprised of 2% CHG in 70% isopropyl alcohol. ChloraPrep® \[CareFusion Inc., Leawood, KS, USA\] will be the product used.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With a Superficial Incisional Surgical Site Infection (SSI)Time frame: Within 30 days of the patient's last planned fracture management surgery
- Number of Participants With a Deep Incisional InfectionTime frame: Within 90 days of the patient's last planned fracture management surgery
Locations
27 sites in 2 countries. Site status is shown where the registry gives one.
University of California, Irvine
Irvine, California
Cedars Sinai
Los Angeles, California
Regional Medical Center of San Jose
San Jose, California
Indiana University Health Methodist Hospital
Indianapolis, Indiana
Louisiana State University
Baton Rouge, Louisiana
University of Maryland, R Adams Cowley Shock Trauma Center
Baltimore, Maryland
University of Maryland Capital Region Health
Cheverly, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
Bryan Health
Lincoln, Nebraska
Dartmouth-Hitchcock Medical Center
Hanover, New Hampshire
Carolinas Medical Center, Atrium Health Musculoskeletal Institute
Charlotte, North Carolina
Duke University Hospital
Durham, North Carolina
Wake Forest Baptist University Medical Center
Winston-Salem, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
Case Western / MetroHealth Medical Center
Cleveland, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
Greenville Health System
Greenville, South Carolina
Sanford Health
Sioux Falls, South Dakota
San Antonio Military Medical Center
San Antonio, Texas
University of Utah
Salt Lake City, Utah
Inova Health System Foundation / Inova Fairfax Hospital
Falls Church, Virginia
University of Wisconsin
Madison, Wisconsin
Royal Columbia Hospital
New Westminster, British Columbia, Canada
Hamilton Health Sciences
Hamilton, Ontario, Canada
McMaster University, Center for Evidence-Based Orthopaedics
Hamilton, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.